Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

• Eli Lilly’s stock dives as Mounjaro and Zepbound sales miss, but Citi says buy

  Business - MarketWatch - 2 hours ago

• Honeywell’s stock falls as sales miss and lowered guidance offsets profit beat

  Business - MarketWatch - 6 days ago

• Biogen’s stock hit by soft sales of Alzheimer’s treatment

  Business - MarketWatch - 1 hour ago

• Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

  Business - CNBC - 4 hours ago
• 

  Shares in weight-loss drugmaker Eli Lilly tumble on disappointing sales

  Business - Financial Times - 5 hours ago

More from CNBC

• Super Micro shares plunge 30% as auditor resigns after raising concerns months earlier

  Business - CNBC - 1 hour ago

• U.S. economy grew at a 2.8% pace in the third quarter, less than expected

  Business - CNBC - 2 hours ago

• Ray Dalio is concerned about America postelection: 'Both candidates worry me'

  Business - CNBC - 1 hour ago

• Apple updates MacBook Pro laptops with new chips, more memory for AI

  Business - CNBC - 1 hour ago

• Meta set to report Q3 earnings after the bell

  Business - CNBC - 1 hour ago